Royal Bank of Canada’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Royal Bank of Canada’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10,500	Closed	-$66K	–	6496
2013 Q2	$66K	Buy	+10,500	New	+$62.9K	﹤0.01%	4536

Other funds holding PBTH

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royal Bank of Canada's PBTH Position: Q3 2013 in Review

Royal Bank of Canada sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 10,500 shares — an estimated $66K sold.

Royal Bank of Canada first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $66K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Royal Bank of Canada reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Royal Bank of Canada sold 10,500 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $66K.
Royal Bank of Canada first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Royal Bank of Canada's PROLOR Biotech, Inc. Common Stock position peaked at $66K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Royal Bank of Canada's 13F filing for Q3 2013, filed 14 Nov 2013.